Literature DB >> 26804303

Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China.

Ninghui Guo1, Wencheng Xue2, Dahai Tang3, Jinya Ding4, Bin Zhao5.   

Abstract

The purpose of this study was to determine the risk factors and outcomes of bloodstream infections caused by multidrug-resistant (MDR) Acinetobacter baumannii complex in a hospital of Northern China. Risk factors associated with MDR A baumannii complex included older age, pneumonia, using drainage catheters, and intensive care unit stay. Multivariate analysis showed that multidrug resistance and mechanical ventilation were identified as independent risk factors for 30-day mortality in patients with A baumannii complex bacteremia.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Risk factors; bloodstream infections; multidrug-resistant Acinetobacter baumannii complex; outcomes

Mesh：

Year:  2016        PMID： 26804303     DOI： 10.1016/j.ajic.2015.11.019

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  9 in total

1.  Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision.

Authors:  Ying Wang; Xinping Zhang; Xuemei Wang; Xiaoquan Lai
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

2.  Subsequent Multidrug-Resistant Bacteremia Is a Risk Factor for Short-Term Mortality of Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter baumannii in Intensive Care Unit: A Multicenter Experience.

Authors:  Mo-Han Ju; Yu-Long Yao; Chun-Ling Du; Shu Chen; Yuan-Lin Song
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

3.  Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia.

Authors:  Tala Ballouz; Jad Aridi; Claude Afif; Jihad Irani; Chantal Lakis; Rakan Nasreddine; Eid Azar
Journal:  Front Cell Infect Microbiol       Date:  2017-05-04       Impact factor: 5.293

4.  Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study.

Authors:  Shuangshuang Yang; Jide Sun; Xianan Wu; Liping Zhang
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-06-03       Impact factor: 2.471

5.  Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.

Authors:  Hua Zhou; Yake Yao; Bingquan Zhu; Danhong Ren; Qing Yang; Yiqi Fu; Yunsong Yu; Jianying Zhou
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  Multicenter Study of the Risk Factors and Outcomes of Bloodstream Infections Caused by Carbapenem-Non-Susceptible Acinetobacter baumannii in Indonesia.

Authors:  Dewi Anggraini; Dewi Santosaningsih; Pepy Dwi Endraswari; Novira Jasmin; Fajri Marindra Siregar; Usman Hadi; Kuntaman Kuntaman
Journal:  Trop Med Infect Dis       Date:  2022-07-31

7.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured During the Eastern Ukrainian Conflict.

Authors:  Heike Granzer; Ralf Matthias Hagen; Philipp Warnke; Wolfgang Bock; Tobias Baumann; Norbert Georg Schwarz; Andreas Podbielski; Hagen Frickmann; Thomas Koeller
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-05-17

8.  Rare purulent pericarditis caused by carbapenem-resistant Acinetobacter baumannii: A case report.

Authors:  Jingjing Liu; Xuefei Xiao; Chaoqun Cen; Hong Yuan; Mingshi Yang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

9.  Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings.

Authors:  Mariana Neri Lucas Kurihara; Romário Oliveira de Sales; Késia Esther da Silva; Wirlaine Glauce Maciel; Simone Simionatto
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.